Glooko Appoints Alfonso “Chito” Zulueta, former Eli Lilly & Company Senior Executive, to Board of Directors
PALO ALTO, Calif., April 28, 2022 /PRNewswire/ -- Glooko, Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the appointment of Alfonso "Chito" Zulueta to its Board of Directors. Respected as a leader with a strong track record of success in the...
Communique from annual general meeting in Mentice AB
STOCKHOLM, April 27, 2022 /PRNewswire/ -- An annual general meeting was held in Mentice AB on 27 April 2022. Below follows a summary of the resolutions made at the meeting. Adoption of the income statement and the balance sheet, the consolidated income statement and the consolidated balance sheet and discharge from liability At the annual general meeting the income statement...
AIG Announces Widespread Growth in Q1 2022
Results Reflect Growing Demand for High-Quality Live Social Platforms NEW YORK, April 27, 2022 /PRNewswire/ -- Asia Innovations Group (AIG) today announced phenomenal growth in the first quarter of 2022. This growth spans across products, but is especially pronounced in AIG's live social platform Uplive, demonstrating the growing demand for genuine human connections online. According to industry monitor Sensor...
3M Petrifilm Plate Reader Advanced wins gold at 2022 Edison Awards
ST. PAUL, Minn., April 27, 2022 /PRNewswire/ -- 3M Food Safety was named a 2022 Edison Awards™ gold winner in the Commercial Technology category for its 3M™ Petrifilm™ Plate Reader Advanced. The Edison Awards globally recognize, honor and foster innovations and innovators whose solutions make a positive impact in the world. ...
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, April 27, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on April...
Alterity Therapeutics Announces Regulatory Authorization to Proceed with ATH434 Phase 2 Clinical Trial in the United Kingdom
MELBOURNE, Australia, April 27, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that the United Kingdom Medicines & Healthcare products Regulatory Agency (MHRA) has accepted Alterity's clinical trial authorisation (CTA) request to conduct its...
HistoIndex and Global Liver Experts Advance Stain-free AI Quantification of Hepatocyte Ballooning as a Reproducible Approach and Potential Endpoint for NASH Clinical Trials
This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a more reliable way to assess the range of injury recorded as "hepatocyte ballooning" as a clinical trial endpoint by expert hepatopathologists. Reliable identification of ballooning is crucial for patient enrolment and drug efficacy evaluation. There is a pressing...
Mentice publishes the company’s interim report for the period January-March 2022
STOCKHOLM, April 27, 2022 /PRNewswire/ -- A strong start for the year with continued overall growth Our strong finish of 2021 is now followed by a first quarter of 2022 with considerable growth for both order intake and net sales. We increased the order book to 91.4 (72.9) MSEK compared to the end of 2021 (87.1) MSEK. The...
Samsung Biologics Reports First Quarter 2022 Financial Results
Q1'22 revenue of KRW 511.3 billion increased 96% compared to Q1'21. Q1'22 operating profit of KRW 176.4 billion increased 137% compared to Q1'21. Stable business operations and utilization rates across Plants 1, 2, and 3. Proactive investments into long-term growth, capacity, and sustainability. INCHEON, South Korea, April 27, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's...
Zymo Research Makes Strategic Investment in Star Array to Develop an Automated Nucleic Acid Extraction/Superfast PCR Platform for the POCT Market
IRVINE, Calif., April 27, 2022 /PRNewswire/ -- Zymo Research and Star Array today announced Zymo Research's strategic investment to acquire an interest in Star Array, a privately owned, biomedical technology company based in Singapore. The investment allows Zymo Research and Star Array to combine Zymo Research's nucleic acid purification and assay...
